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Abstract
Background: Dengue is an arthropod-borne viral disease responsible for approximately 400 million infections
annually; the only available method of prevention is vector control. It has been previously demonstrated that
insecticide treated curtains (ITCs) can lower dengue vector infestations in and around houses. As part of a larger
trial examining whether ITCs could reduce dengue transmission in Iquitos, Peru, the objective of this study was to
characterize the participants’ experience with the ITCs using qualitative methods.
Methods: Knowledge, attitudes, and practices (KAP) surveys (at baseline, and 9 and 27 months post-ITC distribution,
with n = 593, 595 and 511, respectively), focus group discussions (at 6 and 12 months post-ITC distribution, with
n = 18 and 33, respectively), and 11 one-on-one interviews (at 12 months post-distribution) were conducted with
605 participants who received ITCs as part of a cluster-randomized trial.
Results: Focus groups at 6 months post-ITC distribution revealed that individuals had observed their ITCs to
function for approximately 3 months, after which they reported the ITCs were no longer working. Follow up
revealed that the ITCs required re-treatment with insecticide at approximately 1 year post-distribution. Over half
(55.3 %, n = 329) of participants at 9 months post-ITC distribution and over a third (34.8 %, n = 177) at 27 months
post-ITC distribution reported perceiving a decrease in the number of mosquitoes in their home. The percentage of
participants who would recommend ITCs to their family or friends in the future remained high throughout the study
(94.3 %, n = 561 at 9 months and 94.6 %, n = 488 at 27 months post-distribution). When asked why, participants
reported that ITCs were effective at reducing mosquitoes (81.6 and 37.8 %, at 9 and 27 months respectively), that they
prevent dengue (5.7 and 51.2 %, at 9 and 27 months), that they are “beautiful” (5.9 and 3.1 %), as well as other reasons
(6.9 and 2.5 %).
Conclusion: ITCs have substantial potential for long term dengue vector control because they are liked by users, both
for their perceived effectiveness and for aesthetic reasons, and because they require little proactive behavioral effort on
the part of the users. Our results highlight the importance of gathering process (as opposed to outcome) data during
vector control studies, without which researchers would not have become aware that the ITCs had lost effectiveness
early in the trial.
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Background
With an estimated 96 million apparent (or symptomatic)
infections and an additional 294 million inapparent
(or “asymptomatic”) infections globally in 2010, dengue vi-
ruses (DENV) are the cause of more human morbidity
and mortality than any other arthropod-borne virus [1].
The public health burden of dengue in the Americas is
particularly high with 2.3 million dengue cases reported in
2013, the greatest number to date [2]. Peru is one of the
countries in the Americas that is at greatest risk, reporting
nearly a third of the region’s dengue cases in 2013 [3].
Aedes aegypti and Aedes albopictus mosquitoes, dengue
virus vectors in Latin America, also transmit Chikungunya
and Zika viruses, which are increasing as well [4, 5].
Currently, vector control is the only tool available to
prevent and control dengue transmission (as well as
Chikungunya and Zika), as vaccines and anti-viral medi-
cations remain in development and testing phases [6–8].
Most vector control strategies target immature Aedes
aegypti mosquitoes, typically in containers used for
water storage near the human habitations where they
proliferate; such strategies only decrease mosquito vec-
tor density and do not reduce the longevity of adult
mosquitoes [9]. While interventions using insecticide
sprays that target adult Ae. aegypti do exist, they are
labor intensive to deliver inside homes where the mos-
quitoes live and typically only kill mosquitoes during a
short time period (i.e., they have limited efficacy and
residuality), and are therefore used primarily in response
to outbreak situations [10–13]. Insecticide-treated cur-
tains (ITCs) and insecticide-treated screens can be an ef-
fective household-level Ae. aegypti control measures that
reduce the number of adult mosquitoes in homes [14–18].
A challenge with the approach, however, is that their use
can significantly decline in the long-term [19, 20]. A study
in Venezuela and Thailand found that household-use de-
creased to 59.7 % after 18 months, and further declined to
38.4 % after 22 months [21]. In order for ITCs to be an ef-
fective vector control tool, it is imperative to understand
why people do or do not accept and continue to utilize
ITCs over time.
Many quantitative and qualitative studies have been
conducted about the use of insecticide-treated materials
(ITMs) as vector-control interventions for malaria
prevention, such as bed nets and durable wall linings
[22–29], yet little research has been conducted on the
acceptability of ITCs as a vector control intervention
for dengue and other viruses transmitted by Aedes.
One dengue prevention study conducted in Venezuela
and Thailand found that participants were more likely
to accept and use ITCs if the curtains were perceived
as being effective [19], although a qualitative component
to understand why people did or did not like ITCs was
not included in that study. Patients’ compliance (or lack
of) is an underestimated aspect of vector control mea-
sures, and can result in poor evaluations of the effective-
ness of a given intervention.
As part of a larger cluster randomized trial examining
whether ITCs could reduce Ae. aegypti populations and
DENV transmission in Iquitos, Peru, the objective of this
study was to qualitatively characterize participants’ ex-
perience with the ITCs during the trial. Related to this
study, other analyses have been conducted focusing on
this population’s overall knowledge, attitudes, and den-
gue prevention practices, as well as factors associated
with correct and consistent use of the ITCs (based on
the research team’s curtain monitoring), which were re-
cently published [20, 30]. This manuscript specifically
focuses on the experiences with the ITCs by those who
had the ITCs in their homes: i.e., what they liked, what
problems they had. By understanding what participants
like or do not like about ITCs, ITC intervention pro-
grams can develop more effective strategies for commu-
nity acceptance and sustained proper use of this tool for
dengue prevention.
Methods
Study setting
Iquitos, Peru is a large (population ~400,000), geograph-
ically isolated city in the Amazon Basin that is only ac-
cessible by boat or plane [31]. This study was conducted
in the southern-most extent of the urban part of the city
located in the district of San Juan. There is excellent in-
frastructure for monitoring local dengue transmission
and vector populations because extensive dengue epi-
demiology studies have been conducted in Iquitos since
1999 by the University of California at Davis/U.S. Naval
Medical Research Unit-6 (NAMRU-6) [20, 30, 32–41].
As such, experienced research teams are in place to col-
lect and monitor entomological and serological data, as
well as collect and analyze quantitative and qualitative
data related to people’s knowledge, beliefs and practices
associated to preventing dengue and other vector-borne
diseases.
Study design
This study was part of a cluster-randomized controlled
trial, initiated in October 2009, to measure whether ITCs
could reduce DENV transmission and mosquito vector
density in 10 treatment clusters compared to ten control
clusters of approximately 70 households each (2–3 city
blocks). The ITC intervention consisted of distribution
and installation of PermaNet 2.0 (Vestergaard, Lausanne,
Switzerland) curtains [42], factory treated with a long last-
ing formulation of the insecticide deltamethrin. Serology
samples and entomological surveys were collected every 9
and 6 months, respectively, both in the intervention and
control clusters. Weeks prior to ITC distribution, we
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asked one resident from each intervention and control
household to participate in a survey about knowledge, at-
titudes and practices (KAP) associated with dengue and
mosquito control [30]. The ITCs were then distributed to
593 intervention households between November and
December 2009. Follow up KAP surveys, interviewing the
same individuals that had been interviewed previously
(with up to eight visits at mornings, afternoons or evening
hours to find that same individual), were carried out at 9
and 27 months post-ITC distribution, and a curtain moni-
toring checklist was conducted at 9 and 18 months post-
distribution [20]. After the initial distribution of ITCs, 12
households in the intervention cluster became interested
in participating after seeing the ITCs; hence, at 9 months,
there were 605 intervention households, and at 27 months
there were 516 intervention households. Data used
for this analysis comes from the 593 intervention
households that participated in the baseline KAP, and
the 595 and 511 intervention households, from months 9
and 27 respectively, with complete data for all the vari-
ables in this analysis.
Focus group discussions (FGDs) were conducted at 6
and 12 months post-distribution, and one-on-one inter-
views at 12 months post-distribution. During the 2 FGDs
at month six post-distribution, participants (n = 18) re-
ported the ITCs had stopped killing insects after
~3 months. A sample of ITCs were pulled from house-
holds and the efficacy of the deltamethrin was tested
using standard WHO cone bioassays [43]. Results from
the cone bioassays showed reduced bioefficacy of the
ITC material, consistent with reports during FGDs that
the ITCs seemed to stop working after ~3 months. Hence,
at 12 months into the study, ITCs were removed from
homes, re-treated with deltamethrin (K-O tab, Bayer), and
returned to their original location in the homes.
Surveys
A baseline KAP survey of the households was conducted
between October-December 2009 – prior to and during
the time of ITC distribution. We asked to interview the
person who would be managing the ITCs and makes re-
lated decisions in the home, which was usually the
housewife. The first KAP survey that included questions
regarding the participants’ experience with the ITCs was
conducted after the ITCs had been in place for 9 months,
between July–October 2010—this survey was conducted
with the same individual interviewed at baseline (after 8
unsuccessful attempts to find the person, we interviewed
another household decision maker who also took care of
the home and the ITCs). The final KAP survey including
a section on the participants’ experience with the ITCs
was conducted 27 months after initial distribution
(February–April 2012), again, with the same individual
who had responded to previous KAP surveys (and again,
after eight unsuccessful attempts, we interviewed another
household decision maker who cared for the home and
the ITCs). A few observations were missing responses to
some of our key variables of interest for this manuscript,
so we analyzed data from the individuals from intervention
area for whom we had complete KAP data at 9 months
(n = 595), and at 27 months (n = 511). Written consent
was obtained from all who participated in the KAP
surveys at baseline, 9 and 27 months post-distribution.
The KAP surveys were developed, piloted, and modi-
fied by the lead social scientist working with the research
team in Iquitos. This also served as training for the re-
search assistants and ensuring consistency in document-
ing responses between them. Most of the questions were
closed-ended, except for a few, including: for how many
months did the ITCs seem to work, why would you rec-
ommend the ITCs to someone else in the future, and
how many ITCs would you request in the future if you
could pick a number again. Responses to these questions
were coded and categorized based on themes that came
up, whereas responses to the closed-ended questions
had been developed based on preliminary work piloting
the surveys.
Focus group discussions and interviews (Table 1)
Convenience sampling was used to select FGD partici-
pants. Specifically, due to our experience with low turn
out when setting up times in advance for FGD, on the
day of the FGD, about 2 hours prior to the scheduled
time, our field teams went to 3 intervention blocks that
were near to one another (to make picking participants
up for transport to the FGD site easier), and described
to people they found in their homes about the FGD and
if they would be willing to participate. Three assistant-
s—one at each block—each were asked to recruit 3–4
people, with the instruction of ensuring that the houses
had at least 4 houses of distance from one another.
Assistants stopped mototaxis/rickshaws to take the
FGD participants to the FGD site, where 2 FGDs with 18
individuals were conducted in January 2010, 6 months after
initial ITC distribution. Three additional FGDs (n = 33 in-
dividuals) were conducted in June 2011 (12 months after
initial ITC distribution and following ITC re-treatment
Table 1 Summary of focus group discussions and interviews
conducted in Iquitos, Peru
Group No. FGD/
Interviews
No.
Participants
Focus groups – 6 months after distribution 2 18
Focus groups – 12 months after distribution 3 33
One-on-one interviews – 12 months after
distribution
11 11
Total – 62
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with insecticide). In June 2011, 11 one-on-one inter-
views were also conducted with participants who had
rejected the ITCs after having them in their home for
at least a week.
The FGD facilitator and interviewer of the one-on-one
interviews was a Peruvian social scientist experienced at
facilitating FGDs and interviews on vector-related topics
in Iquitos. The emphasis of the FGDs conducted
6 months post-ITC distribution was to ascertain where
the ITCs had been hung in the home, ask about the
advantages and disadvantages of each location, obtain
overall comments from participants about their experi-
ences with the ITCs up to that time, and allow the partici-
pants to ask questions related to the ITCs. Participants
were asked if they experienced any issues with the ITCs
and if they would accept ITCs again. During the FGDs
held at 12 months, participants were asked about changes
in utility of the ITCs since their initial distribution or after
the first re-treatment with insecticide. The FGD at
12 months also included a discussion on the participants’
reaction to the need for re-treatment. The eleven
one-on-one interviews were semi-structured and focused
on exploring the reasons why the participants had rejected
having the ITCs in the home.
Informed verbal consent was obtained from all partici-
pants. Detailed notes were taken during the FGDs and
interviews by study personnel. After the FGDs and the
interviews, the note-taker who was recording during the
FGDs and other research team members compared their
notes to ensure inclusion of all notes and comments in
the final written documentation of the FGDs. Digital re-
cordings were made of the FGDs to aid with the writing
of the detailed documentation, but were not transcribed.
Data analysis
Responses from the KAP surveys were analyzed using
STATA 12.0 [44]. Frequencies for close-ended questions
were tabulated; responses to open-ended questions were
coded manually and then tabulated.
Open ended responses to survey questions were syn-
thesized into categories for quantification purposes. For
example, when asked in an open-ended question why
they would or would not recommend ITCs to their fam-
ily or friends at 9 months after ITC distribution, answers
were collapsed into the four main themes that emerged:
prevents dengue, reduces the amount of mosquitoes,
ITCs are beautiful, and other. The category “prevents
dengue” included those who responded that the ITCs
specifically prevented dengue or protect one’s health.
The category “reduces the amount of mosquitoes” in-
cluded the following participant responses: protects
against mosquitoes, reduces the amount of mosquitoes,
kills mosquitoes, kills all insects, or feels the ITCs are ef-
fective. The category “ITCs are beautiful” included those
who responded to the aesthetic properties of the ITCs,
i.e., “beautiful”, “decorative”, “to adorn one’s house” or
“elegant”. The category “other” included all other partici-
pant responses, including “privacy”, “security”, “free”, or
“economical”. FGD and interview data was coded manu-
ally and summarized based on themes of interest.
Ethics statement
This trial received approval from the Institutional Re-
view Boards (IRBs) at the Liverpool School of Tropical
Medicine (09.59), the Tulane School of Public Health
and Tropical Medicine (166680–4), and the U.S. Naval
Medical Research Unit-6 in Peru (NMRCD.2009.0007).
The Tulane School of Public Health and Tropical Medi-
cine and the University of California at Davis also had
an inter-institutional IRB agreement with the U.S. Naval
Medical Research Unit-6. The Loreto Regional Govern-
ment was also informed of this study in writing, and
gave their approval for this study to proceed (letter
#586-2009-GRL-DRS/30.09.01). Written consent was ob-
tained for participants who participated in the surveys,
and verbal consent was obtained from each participant in
the FGD for: 1) voluntary participation in the FGD and 2)
having the FGD audiotaped.
The trial was registered with the International Stand-
ard Randomized Controlled Trial Number Register:
ISRCTN08474420. This manuscript does not report
the outcome of the cluster randomized trial. The in-
vestigation was carried out only on the treatment
group; the control group in the study received no
treatment. Therefore this study is not an analysis that
is dependent on randomized control trial (RCT) design,
but instead measures perceptions of the intervention tool:
the ITCs.
Results
KAP participant characteristics
The median age of KAP participants in the intervention
clusters was 39 years and most participants were female
(76.7 %). Almost 80 % of participants had less than or
equal to 11 years of education and the primary occupa-
tion was housewife (48.7 %). The median number of
people living in the households was five, including adults
and children. One fifth of houses had a child under the
age of three living in the home. Each household decided
on the number of ITCs they would receive: the median
number of ITCs distributed per house in this study was
five, with a range of 1 to 15.
KAP surveys
Perceived effectiveness
At 9 months post-ITC distribution, over half of partici-
pants responded that they saw a drop in the amount
of mosquitoes in the home (the proxy variable for
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perceived effectiveness), but a third of participants
responded that they saw a drop only for a few months
(Table 2). By 27 months after distribution, the percentages
had switched so that over half of the participants reported
seeing the drop for only a few months and only a third re-
ported seeing a decrease in the amount of mosquitoes
throughout the study period. The average number of
months that the ITCs were reported as functioning was
3.3 months and 4.7 months at 9 months and 27 months,
respectively (Table 2).
Reasons for recommending ITCs
The majority of participants at 9 and 27 months after
distribution responded that they would recommend the
ITCs to family or friends: 94.3 % at 9 months and 94.6 %
at 27 months (Table 2). Approximately 97 % of those
who perceived a change in the number of mosquitoes in
their home, even if for just some months, would recom-
mend the curtains (both at 9 and 27 months). Interest-
ingly, 62.1 and 75.7 %, at 9 and 27 months respectively,
would recommend the use of ITCs even if they did not
Table 2 Participant perception of ITC effectiveness and future use at 9 and 27 months after initial distribution in Iquitos, Peru
(KAP surveys: n = 595 at 9 months, n = 516 at 27 months)
9 months % (n) 27 months % (n)
Saw a decrease in the amount of mosquitoes
No 9.8 (58) 9.6 (49)
Yes, but only for a few months 35.0 (208) 55.7 (285)
Yes 55.3 (329) 34.8 (177)
Doesn’t know 1.0 (5)
Average number of months that the ITCs functioned (at 9 mos: n= 205; at 27 months: n= 284)a 3.3 months (range 1–8) 4.7 months (range 1–24)
Percent who would recommend ITCs to family or friends 94.3 (561) 94.6 (488)
If they saw a decrease in mosquitoes (even if just for a few months), would they recommend ITCs? 97.8 (525) 97.0 (462)
If they did not see a decrease in mosquitoes, would they recommend ITCs? 62.1 (36) 75.7 (37)
Reasons for recommending ITCsb (at 9 months: n = 561; at 27 months: n = 488)
Reduces the amount of mosquitoes 81.6 (460) 37.8 (195)
Protects against dengue 5.7 (32) 51.2 (264)
Beautiful/aesthetically pleasing 5.9 (33) 3.1 (16)
Other 6.9 (36) 2.5 (13)
Reasons for not recommending ITCsb (at 9 months, n = 34; at 27 months, n = 28)
Did not see a decrease in mosquitoes 32.3 (10) 39.3 (11)
ITCs “not effective” 45.2 (14) 35.7 (10)
Other 22.6 (7) 17.9 (5)
No response 9.7 (3) 7.1 (2)
What they liked about the ITCs
Saw fewer mosquitoes in the home 44.0 (262) 36.8 (190)
Looked beautiful/elegant 25.4 (151) 27.3 (141)
Saw dead mosquitoes on the ITCs 15.8 (94) 24.6 (127)
Saw all types of dead insects dead on the ITCs 9.9 (59) 7.4 (38)
Other 4.4 (26) 3.7 (19)
Missing 0.5 (3) 0.2 (1)
What problems were experienced with the ITCs
No problems 78.0 (464) 77.0 (397)
Allergic skin reaction 19.2 (114) 20.2 (104)
Respiratory reaction 3.2 (19) 2.1 (11)
Got easily dirty/damaged where they were located 0.5 (3) 0.2 (1)
Interfered with movement in the house 0.2 (1) 0.6 (3)
aThere were three outliers in the 9 months survey (who responded “15 months” or “24 months” when ITCs had only been out for 9 months), and one respondent
who “did not know” how many months the ITCs had worked well in the 27 months survey. These four outliers were removed from the calculation of the mean
bParticipants were asked to respond to these open-ended questions in the 9 month KAP survey and the responses were collapsed into these four categories
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perceive a difference in the number of mosquitoes in
their homes.
Participants were asked to elaborate through an open
ended question why they would or would not recom-
mend ITCs and answers were recorded, coded, and
based on the themes that emerged, collapsed into four
categories. At 9 months, the majority (81.6 %, n = 460)
of those who would recommend ITCs reported it was
because they reduce the number of mosquitoes; 5.7 %
(n = 32) of participants specifically responded that the
ITCs prevented dengue, which was the primary aim of
the ITCs in this study. However, at 27 months, more
than half (51.2 %, n = 264) of participants reported they
would recommend ITCs because they protect against
dengue and other illnesses. It is important to note that
many participants’ first response was that the ITCs re-
duced the number of mosquitoes (the proxy variable for
perceived effectiveness), but these responses were quickly
followed by stating that ITCs were not long-lasting in
their protection. Other reasons given for why ITCs would
be recommended included that they provided security,
privacy (i.e., some ITCs were used as doors to bathrooms
or bedrooms since some houses did not have doors) and
“overall protection” for the family (not specifying for what
or how). Additionally, participants mentioned that the
ITCs were good because they were more economical than
other mosquito control measures, as they were given free
of charge to study participants.
Among those who would not recommend ITCs (n = 34
at 9 months and n = 28 at 27 months), the top two reasons
cited for why they would not recommend ITCs were that
the ITCs were not effective (45.2 and 35.7 %, at 9 and
27 months, respectively) and that they perceived no
difference in the amount of mosquitoes in the home (32.2
and 39.3 %, at 9 and 27 months, respectively) (Table 2).
Likes and dislikes
The participants were asked what they liked most about
the ITCs (Table 2). The top three items reported at 9 and
27 months was seeing fewer mosquitoes in their homes
(44 and 36.8 %, at 9 and 27 months, respectively), feeling
that the ITCs were beautiful/elegant (25.4 and 27.3 %, re-
spectively), and seeing mosquitoes and other insects dead
on the ITCs or the floor underneath. When asked if they
had any problems with the ITCs, over three quarters of
participants reported “none” at 9 and 27 months. The most
common problem reported was an allergic skin reaction
(19.2 %, n = 114 at 9 months, 20.2 %, n = 104 at 27 months),
with a small percentage reporting a respiratory reaction
(3.2 % n = 19 at 9 months, 2.1 %, n = 11 at 27 months).
Future curtain use
At 27 months, the majority of participants (85.3 %,
n = 440) responded that they would select ITCs again
at the end of the study. A median of five ITCs would be
requested per household (range 1–29), which is equal to
the median number of ITCs that were requested and dis-
tributed per household in this study. Pink was the most fa-
vored color (31.4 %, n = 847), followed by sky blue (25.1 %,
n = 677) and dark blue (25.0 %, n = 674) (Fig. 1). Most par-
ticipants reported wanting to place their ITCs in the door
(43.8 %, n = 1172) or as a room divider (37.1 %, n = 997)
(Fig. 2), despite the fact that we found that ITCs placed in
these locations were most likely to be tied up during the
day, whereas those on walls were most likely to remain in
place and out of the way throughout the day [20]. It is
Fig. 1 Number of ITCs requested by color, 27 months after distribution in Iquitos, Peru. (n = 2697)
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important to note that the questions regarding preferred
ITC color and placement location for ITCs were open
ended, as was the question regarding how many ITCs they
would select, and when respondents answered to the three
separate questions, the numbers for the ITCs did not add
up, hence the difference in ITCs in Fig. 1 (n = 2697) and
Fig. 2 (n = 2675).
Other mosquito control products
At baseline, when asked about products used for mosquito
control, most reported using mosquito nets (84 %); petrol-
eum, creoline or bleach on their floors (45.2 %), and insect
sprays or slow-burning insecticide coils (36.7 %). More-
over, related to external interventions (usually carried out
by the local Ministry of Health), fumigation and larvicid-
ing was reported in 53.1 and 58 % of the houses, respect-
ively. Most participants at 9 and 27 months post-ITC
distribution reported using the same amount of certain
mosquito control products over the preceding 9 months.
However, there was a reported reduction in use of prod-
ucts at both time periods: when asked about specific prod-
ucts, and if they were using them more, less, or in the
same amount compared to 9 months prior, 17.5 % re-
ported using their mosquito nets less; 38 % reported using
less of the petroleum, creoline, or bleach on their floors;
and 55.6 % reported less use of insecticide sprays or the
slow-burning insecticide coils. Reported use of these prod-
ucts decreased further at 27 months: 12.2 % reported
using mosquito nets less; 15.8 % reported using less of the
petroleum, creoline, or bleach on their floors; and 36.7 %
reported less use of insecticide sprays or the slow-burning
insecticide coils. At the 9 months survey, participants also
reported that there had been less fumigation/larviciding in
their homes in the previous 9 months (~20 %), and at the
27 months survey, ~10 % reported less fumigation/larvi-
ciding in their homes in the previous 9 months. The main
reason given for reducing their use of all products was
that they perceived a drop in the amount of mosquitos in
the home.
Focus groups discussions and interviews
Advantages and disadvantages at 6 months
The two FGDs at 6 months post-distribution were con-
ducted only with women, because they reported that
they were the ones in charge of managing their homes
and making decisions regarding whether to and where
to hang ITCs. Participants liked the ITCs because they
saw them working instantly: “They work well: you could
see all kinds of dead insects at the bottom of the ITCs,
even cockroaches and spiders….” The enthusiasm among
all participants was clear. However, very early on in the
discussion of both FGDs, one participant mentioned,
“They worked well for a few months, but then they
stopped working. You could see dead insects on the floor
of your house when we first placed the ITCs, but then
after a few months, you didn’t see any dead insects any
more…” Once one woman raised the issue, all the other
participants agreed; this happened independently in both
FGDs, resulting in the women reporting that the ITCs
were effective, but only for 2–6 months after the initial
distribution. As a result of the ITCs’ initial effectiveness,
the participants commented that they decreased use of
other mosquito repellents, no longer had to use bed nets
at night because there were fewer mosquitoes in the
home, or stopped fumigating: “After 2 months they came
to fumigate and I didn’t allow them to because it was no
longer necessary…because I had the curtains.”
The participants perceived the ITCs to be “beautiful”
and noted that they would continue to hang the ITCs in
their homes for decorative value, even if they were no
longer effective at controlling mosquitoes. Some partici-
pants reported that family and friends were envious of
Fig. 2 Number of ITCs requested by location, 27 months after distribution in Iquitos, Peru. (n = 2675)
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the ITCs and asked if they could borrow the ITCs. One
participant told of loaning her ITCs to a relative organiz-
ing a birthday party for her child in order to beautify her
home. The ITCs were also reported to provide additional
privacy in the home, particularly as a “separator between
beds, it gives privacy.” At this point in time, most ITCs
did not require mending (only six had been mended, albeit
5.5 % (159) of the ITCs were observed by our research
team to be in poor state [20]) and participants reported
that all colors of the ITCs were working equally well at
controlling mosquitoes. There were also placement prefer-
ences based on ITC colors and how these were perceived:
the pink ITCs were considered more “elegant” by FGD
participants and were selected for placement in locations
such as their living rooms, whereas the dark blue ITCs
were harder to see through and, hence, selected for loca-
tions where the participants might want more privacy,
such as bathroom or bedroom doors.
Similar to the findings from surveys, there were few
‘dislikes’ reported. The main problems included that the
ITCs were initially itchy or stingy on the skin because of
the insecticide (but that itchy feeling had disappeared
after the first week), that the ITCs could not be moved
once placed because the study team told them not to
move the ITCs, and that the ITCs got dirty quickly and
could not be washed quickly enough to keep clean:
“Both colors (pink and blue) get equally dirty – they get
dirty quickly.”
All participants stated they used the ITCs in the way
they were expected to (i.e., left hanging loosely), but in
every group several women mentioned tying up the ITCs
during certain times of the day to avoid physical contact
with the ITCs, particularly if the ITCs were hung in the
door or passageway. One mentioned, for example,“I have
to tie it up during the day because it bothers the clients
who come to my house for my photocopy business” (the
ITC is near the machine). She would then let it hang
loosely again in the evening and overnight. Some felt
that the wear and tear on some ITCs was high due to all
the movement in certain locations of their home.
The FGD participants also noted creative uses for the
ITCs, which were not consistent with the study instruc-
tions. For example, multiple participants reported turning
the ITC into a bed net to sleep under (either for themselves
or children): “it is safer as a mosquito net – it is better be-
cause it protects more at night”. One participant took her
ITCs back and forth with her to her farm on the outskirts
of Iquitos because she wanted the protection of the ITCs
while at her farm.
Information arising from this set of FGDs regarding a
perceived drop in the effectiveness of the ITCs led to
an increase in the number of curtains that were tested
for insecticide bioefficacy between 6–12 months post-
distribution. These FGD data were the first indication
that the ITCs were not functioning as expected, and in-
deed bioefficacy testing corroborated the FGD data. As
a result, all ITCs were collected after 12 months of dis-
tribution and were re-treated with insecticide, and then
returned to the houses.
Advantages and disadvantages at 12 months
A further three FGDs were conducted with female par-
ticipants 12 months post-ITC distribution. These FGDs
aimed to understand how the ITCs were functioning im-
mediately after the re-treatment with insecticide. All of
the FGDs reported the ITCs worked best in the first few
months of use, when they came from the manufacturer;
however, all re-treated ITCs worked better than they had
prior to re-treatment.
The comments about how the ITCs worked after re-
treatment were different than the comments in the first
set of focus groups. At 12 months, the participants
noted that “the amount of mosquitoes only went down
the first time,” but they did not notice a drop in mosqui-
toes after the second re-treatment. Mosquitoes were re-
ported as being stuck to the ITCs after re-treatment,
though they were still alive on the ITCs rather than be-
ing dead like when the ITCs were new. The participants
also commented that the ITCs had a strong smell and
burned the skin after re-treatment. There were also
complaints about the re-treatment process, because it
required study personnel to come repeatedly to the
house; it would have been preferable if study personnel
had arranged set appointments to pick up their curtains
for re-treatment.
When asked if they would rather have future ITC re-
treatments performed inside or outside the home (i.e.,
rather than removing ITCs and re-treating them off-site,
have a research team member re-treat the ITCs at the
participants’ homes), there were mixed responses. Some
participants preferred that it occurred outside the home
due to the believed toxicity of the insecticide and the de-
sire to protect their families’ health. Others wanted the
treatments to be done inside “so I can see how it’s done
and do it myself one day.”
Other comments during the FGDs highlighted the fact
that the ITCs had come to be valued by the participants
as a means to protect against dengue. They reported that
fear of dengue was a motivator for hanging the ITCs
correctly, “I’m more attentive to using [the ITC] after the
second re-treatment, in case of a dengue outbreak.”
Though others noted that they still had to pull the ITCs
aside during the day due to fear of allergies and to allow
transit in their homes.
One-on-one interviews
One-on-one interviews were only conducted with partici-
pants who had rejected or returned their ITCs. The
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reasons for returning their ITCs were similar to those
disadvantages listed during the FGDs. The main concerns
were allergic reactions, inconvenience of the study
staff coming to re-treat the ITCs, and the ITCs’ loss
of effectiveness.
Four of 11 interviewees reported allergic skin reactions
as the reason for rejection. For example, one interviewee
reported that she loved having the ITCs in her home be-
cause they were pretty and there were less mosquitoes,
but that her two young grandchildren had many allergies
and their skin became irritated when they walked by the
ITCs. She would have liked to keep the ITCs, but felt
that she had no option but to return them because of
the allergic reaction of her grandchildren.
Another interviewee mentioned that she had turned
the ITC into a bed net for her baby and did not want
the study staff re-treating it because she feared that the
insecticide would give the child an allergic reaction.
Three interviewees mentioned being inconvenienced by
study personnel constantly coming to the door for
follow-up visits and re-treatment of the ITCs, as well as
the short term effectiveness of the ITCs.
Five interviewees reported that the ITCs were no lon-
ger effective. One interviewee reported that the ITCs
were not effective even after the re-treatment and that
there were many more mosquitoes in her home now.
Another interviewee reported that the ITCs had to be
tied up all day due to their location in the hallway and
she concluded that they were not working well enough
for her to keep them.
Discussion
In the surveys, focus group discussions and one-on-one
interviews, participants reported similar likes and dis-
likes related to the ITCs. The participants perceived that
the ITCs were effective (though the effectiveness was
not long-lasting), decreased the amount of mosquitoes,
and were aesthetically pleasing. These reported advan-
tages are consistent with studies of insecticide treated
nets (ITNs) for malaria prevention conducted in Western
Kenya and rural Malawi. The Kenya study compared
curtains to bed nets for malaria control and, while
overall bed nets were preferred over the curtains, the
study participants did report that the advantages of
the curtains included that they prevented mosquitoes
from entering the home and that they enhanced the
beauty of the home [28]. However, while the Malawi
study found that participants associated the curtains with
reductions in malaria transmission [29], our study did not
consistently show that participants connected the ITCs
with dengue prevention.
The amount of participants who reported they would
recommend ITCs in the future because they prevented
dengue increased from 5.7 % at 9 months to 51.2 % at
27 months after ITC distribution. The increase could be
because the participants learned about the purpose of
the ITCs during repeated visits to their homes for re-
treatment by study staff, despite the fact that they were
told at the start of the study that we were testing whether
the ITCs could prevent dengue. Alternatively, this
may reflect the shift from dengue serotype 4 (August
2008-early 2011) to dengue serotype 2 transmission in
Iquitos [45–47]. The latter serotype was first observed in
late 2010, causing a dramatic epidemic with a much
higher proportion of severe disease than observed during
dengue-4 transmission [45–47]. This dengue outbreak
was highly publicized and overwhelmed local hospitals,
and it occurred between the 9 and 27 months KAP
surveys. Related to these issues, when asked this question,
the respondents’ first answer was documented, so if
respondents had been able to provide more than one
answer, they might have mentioned dengue preven-
tion as a reason to recommend ITCs at both time
points. The shift may reflect a shift in prioritization
rather than a shift in awareness.
There were remarkably few ITC dislikes reported during
FGDs. More than three quarters of participants reported
that they did not have any problems with the ITCs. The
most commonly reported dislike was allergic skin reac-
tions, which were typically described to occur in the first
week or two following placement or re-treatment. This
finding was consistent with the one-on-one interviews in
which a third of interviewees rejected the ITCs due to re-
actions to the insecticide. The FGDs highlighted that they
did not like that the ITCs got dirty so quickly, had to be
washed regularly, and that they could not be moved once
placed by the study personnel. They similarly disliked that
the ITCs had to be re-treated and even then were not per-
ceived to be as effective as when they were brand new.
These findings are similar to a study of insecticide-treated
bed nets conducted in Ethiopia where participants re-
ported that they did not use the ITNs because they had
lost effectiveness [25].
The perception of effectiveness has been shown as im-
portant for acceptability of nets and curtains in other
studies of vector borne diseases. In the Solomon Islands,
the main criterion for acceptability of bed nets was ef-
fectiveness at preventing mosquito bites [22]. A study
conducted in five malaria-endemic areas in three coun-
tries of South America also found the acceptability of
nets was related to participants’ perception of protection
against mosquitoes [48]. In a different analysis of the
Iquitos data, we also found that the odds of recommend-
ing ITCs in the future were significantly greater among
those who perceived the ITCs to be effective [20]. Results
from this study demonstrated that participants accepted
the ITCs even though their perception of effectiveness of
ITCs was short-term. The total percentage of participants
Paz-Soldan et al. BMC Public Health  (2016) 16:582 Page 9 of 13
who would recommend ITCs to family or friends in the
future remained strong at 9 and 27 months after distribu-
tion (94.3 and 94.6 %, respectively), even though the per-
centage of participants who perceived that the ITCs only
functioned for a few months increased from 35 to 55.7 %
at months 9 and 27, respectively. Basically, if an effective
and long-lasting ITC were available, acceptability for these
would be very high and could be a good alternative or
supplement to other vector control activities.
The participants reported in the surveys and the FGDs
that they perceived the ITCs to be attractive and that
they would even keep the ITCs for decorative purposes
even if they ceased to be effective at controlling mosqui-
toes. These findings are consistent with others in the lit-
erature. A study of a durable wall lining for malaria
prevention in Africa and Southeast Asia found that 66 %
of participants would keep their wall lining for decora-
tive purposes even if it lost its effectiveness [24]. Partici-
pants also reported that they would select to have ITCs
again (median = 5), with most preferring pink or sky blue
ITCs because these were considered the most “elegant”
and one quarter preferring dark blue ITCs because these
offered most privacy (i.e., these were often placed in
doorways). A malaria prevention study in the Solomon
Islands also found that dark colored insecticide-treated
nets were preferred by participants for privacy [22].
Therefore, the aesthetic qualities of any vector control
material should always be a consideration.
Creative or incorrect use of nets has been documented
in other studies. In a study of bed nets for malaria pre-
vention in the Solomon Islands, participants were re-
ported as using the nets for fishing or protecting crops
[22]. Similarly, a study of ITNs for malaria prevention
along the shores of Lake Victoria in Kenya found that
participants were using the nets for drying fish and for
fishing [49]. Participants in the Iquitos FGDs also re-
ported that the ITCs were used incorrectly or creatively
at times during our study, such as turning them into bed
nets for children or for other family members to sleep
underneath. This demonstrates that either protection
from nuisance night-time biting mosquitoes was the pri-
ority for some, or that the participants did not under-
stand that the dengue mosquitoes only bite during the
daytime and, therefore, the ITCs should be hung up in
the home during the day, not used as nighttime to pro-
tect against night-time biting mosquitoes [30]. This con-
clusion is consistent with results reported in another
manuscript revealing that only 18.6 % of participants
knew that Ae. aegypti bites during the day or early even-
ing [30]. When the team’s social scientist, who is from
Lima, mentioned this to several people during follow
up interviews, she was told by several that, “In Lima
the mosquitoes might bite during the day time, but in
Iquitos, they bite at night.”
Limitations
The participant population was primarily female, conse-
quently we have little feedback from men regarding the
ITCs. However, in Iquitos, women are mainly responsible
for household management and they were the primary in-
dividuals who interacted with the ITCs. Additionally, the
number of focus groups was limited at both time points,
but the consistency of results suggested that saturation
had been reached regarding the topics explored.
Conclusion
Results from our study highlight the importance of gather-
ing process (as opposed to only outcome) data throughout
the course of a study. The first we became aware that the
curtains were not performing as expected was during
focus group discussions conducted within 6 months of in-
stalling ITCs in people’s homes. The qualitative work that
accompanied the KAP surveys allowed us to detect a
problem in the performance of the intervention and ad-
dress it through re-treatment of the ITCs. It also helped
us further interpret survey data regarding whether people
would recommend the ITCs in the future.
Initial failure of the ITCs demonstrates that their long-
term effectiveness needs to be enhanced, particularly to
address the reported disadvantages about re-treatment
and allergic reactions. We strongly feel that people’s use
and recommendations would have been more favorable
had we not had effectiveness problems within a few
months of ITC installation. Ideally, ITCs should not re-
quire re-treatment or cause allergic reactions. When re-
treatment is necessary, the process should be conducted
in a way that is minimally intrusive to the participants. In
our study it was important for us to keep track of each
ITC and if it was being used correctly. Flexibility, however,
in allowing participants to move their ITCs to other loca-
tions should have been considered. Once the ITCs were
placed in homes, and participants started interacting with
them, they determined that some locations were not as
convenient as others. Similarly, alternative methods for
hanging the ITCs should be considered (e.g., hanging ITCs
in locations that are less likely to result in accidental
physical contact, like along a wall) to reduce adverse
effects experienced by participants.
Participants in our study reported that they would be
willing to continue hanging the ITCs in the home even
if they were no longer effective. Feeling like the curtains
look good in the home, or have alternative uses such as
added privacy, can be helpful in ensuring that the cur-
tains are consistently hung properly in order to provide
protection against mosquitoes.
From an acceptability perspective, ITCs have great po-
tential as a dengue vector control tool. They are well-liked
by users because of their effectiveness and for aesthetic
reasons, and because they require little behavioral input
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from the users. When functioning optimally, their impact
on dengue vectors and DENV transmission will be im-
portant to quantify.
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